EWN | 31 July 2020

The first eight candidates in the province were enrolled in the randomised control trial at the University of Cape Town’s (UCT) Lung Institute on Thursday.

CAPE TOWN – South Africa’s COVID-19 vaccine efficacy trial has been rolled out in the Western Cape.

The first eight candidates in the province were enrolled in the randomised control trial at the University of Cape Town’s (UCT) Lung Institute on Thursday.

The COVID-19 vaccine study, a collaboration between Wits and the UK’s Oxford University, was announced last month.

Potential candidates for the ChAdOx1 nCoV-19 vaccine trial are being screened inside a white marquee tent adjacent to the UCT Lung Institute building.

The international study, that’s also underway at sites in Gauteng, aims to enroll at least 2,000 participants.

Professor Keertan Dheda, head of the Pulmonology Division at Groote Schuur Hospital, explained the importance of having the vaccine efficacy study done locally.

“It’s good that we are doing the trial in South Africa because not everyone responds to vaccines in the same way, the genetic background of a population is different. It would be good to confirm if it works in this setting as well as other settings.”

Dheda said findings were expected in a year’s time.

“That will give us some idea of how well the vaccine might be working. We will know several months before that, but that will give us a good idea whether the vaccine is likely to work or not.”

One-thousand-two-hundred-and-seven people have been screened to participate in the trial, and so far 713 have been enrolled.https://ewn.co.za/2020/07/31/sa-s-covid-19-vaccine-efficacy-trial-rolled-in-the-western-cape

Builder » SEOExportImportTemplates

Turn it ON if you build content using Content Builder Use the Content item if you want to display the Content from editor within the Content Builder
Layout	Full width. No sidebarLeft SidebarRight SidebarBoth Sidebars Full width sections works only without sidebars
Sidebar

Select one from the list of available Layer Sliders
Video | IDYouTube or Vimeo	It`s placed in every YouTube & Vimeo video, for example: YouTube: http://www.youtube.com/watch?v=WoJhnRczeNg Vimeo: http://vimeo.com/62954028
Video | HTML5m4v [.mp4]	Browse Notice: HTML5 video works only in moden browsers
Header Image	Browse
Subheader | Image	Browse
	Options
Subheader | Hide

for Blog Layout: Masonry Tiles & Template: Intro
Intro | Options	Light | light image, dark textFull ScreenParallaxBackground size: Coverenabled by default in parallaxfor Template: Intro
	SEO below settings overriddes theme options
SEO | Title
SEO | Description
SEO | Keywords
Open Graph | Imagee.g. Facebook share image	Browse

SEO

• Readability
• Social

Focus keyphraseHelp on choosing the perfect focus keyphrase(Opens in a new browser tab)Preview as:Mobile resultDesktop resultURL preview:https://lunginstitute.co.za › 2020 › 08 › 08 › pollen-monitoring-in-sa-2-3-3-2-2-2-2-2SEO title preview:SA’s COVID-19 vaccine efficacy trial rolled out in Western Cape – UCT Lung InstituteMeta description preview:

Please provide a meta description by editing the snippet below. If you don’t, Google will try to find a relevant part of your post to show in the search results. VisibilityPublishPost FormatStick to the top of the blogPending reviewAuthor Readability analysis: Needs improvement SEO analysis: Needs improvement
Search CategoriesCLIINewsAIUCHILDCTBRILCRUKTUEventsSocial AwarenessSelect the primary categoryAdd New TagTB (1 of 5)TBProf Keertan Dheda (2 of 5)Prof Keertan DhedaCoronavirus (3 of 5)CoronavirusCOVID-19 (4 of 5)COVID-19ChAdOx1 nCoV-19 vaccine trial (5 of 5)ChAdOx1 nCoV-19 vaccine trial

Separate with commas or the Enter key.Write an excerpt (optional)Learn more about manual excerpts(opens in a new tab)Template:

• Blank Template

Slide Template

• flagInstalled Version6.2.2 cloud_downloadAvailable Version6.2.17
• Unlock All Features

• Document

Search for a block

CAPE TOWN – South Africa’s COVID-19 vaccine efficacy trial has been rolled out in the Western Cape.

The first eight candidates in the province were enrolled in the randomised control trial at the University of Cape Town’s (UCT) Lung Institute on Thursday.

The COVID-19 vaccine study, a collaboration between Wits and the UK’s Oxford University, was announced last month.

Potential candidates for the ChAdOx1 nCoV-19 vaccine trial are being screened inside a white marquee tent adjacent to the UCT Lung Institute building.

The international study, that’s also underway at sites in Gauteng, aims to enroll at least 2,000 participants.

Professor Keertan Dheda, head of the Pulmonology Division at Groote Schuur Hospital, explained the importance of having the vaccine efficacy study done locally.

“It’s good that we are doing the trial in South Africa because not everyone responds to vaccines in the same way, the genetic background of a population is different. It would be good to confirm if it works in this setting as well as other settings.”

Dheda said findings were expected in a year’s time.

“That will give us some idea of how well the vaccine might be working. We will know several months before that, but that will give us a good idea whether the vaccine is likely to work or not.”

One-thousand-two-hundred-and-seven people have been screened to participate in the trial, and so far 713 have been enrolled.